Related Experiment Video

Updated: Aug 27, 2025

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

14.4K

Mitotic Checkpoints and the Role of WEE1 Inhibition in Head and Neck Squamous Cell Carcinoma

Shihan N Khan1, Paul L Swiecicki1, Deborah B Doroshow2

  • 1From the Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

Cancer Journal (Sudbury, Mass.)
|September 27, 2022
PubMed

Insights

WEE1 inhibitors show promise for treating head and neck cancers by causing DNA damage and cell death, especially in TP53-mutant tumors. Further research explores their use alone or with chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • WEE1 kinase is vital for cell cycle control and DNA damage response in cancer.
  • Inhibiting WEE1 causes DNA damage accumulation and cell death, making it a therapeutic target.
  • WEE1 inhibitors are being investigated for head and neck squamous cell carcinomas.

Purpose of the Study:

  • To review preclinical and clinical data on WEE1 inhibitors for head and neck cancers.
  • To assess the efficacy of WEE1 inhibitors as monotherapy and in combination with chemotherapy.
  • To explore their role in TP53-mutant head and neck tumors.

Main Methods:

  • Review of existing preclinical studies.
  • Analysis of ongoing and completed clinical trials.
  • Evaluation of WEE1 inhibitor mechanisms in head and neck cancer models.

Main Results:

  • WEE1 inhibition leads to G2 cell cycle arrest override and DNA damage.
  • Preclinical data suggest potential efficacy in head and neck cancer models.
  • Clinical studies are evaluating WEE1 inhibitors as single agents and chemosensitizers.

Conclusions:

  • WEE1 inhibitors represent a promising therapeutic strategy for head and neck cancers.
  • Their efficacy is particularly noted in TP53-mutant tumors.
  • Further clinical investigation is warranted to establish their role in treatment regimens.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.6K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K

Related Concept Videos

The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.2K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.7K